Form 4: Clover Health Executive Brady Priest Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Brady Priest, CEO of Home Care at Clover Health, disposed of 18,987 shares of Class A Common Stock on January 31, 2025, to cover tax obligations related to vesting restricted stock units.
Summary
- On January 31, 2025, Brady Priest, the CEO of Home Care at Clover Health Investments, Corp., disposed of 18,987 shares of Class A Common Stock.
- The transaction was executed to cover tax obligations arising from the vesting of 12.5% of the original number of time-based restricted stock units (RSUs) granted on October 31, 2023.
- The shares were sold at a price of $4.39 per share.
- Following the transaction, Priest still beneficially owns 2,493,151 shares of Class A Common Stock.
- The remaining RSUs will vest in three equal quarterly installments, with the final vesting date on October 31, 2025, contingent upon continued service.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to executive compensation and tax obligations, which is neutral in sentiment.
Future Outlook
The remaining RSUs will vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often related to compensation packages and tax planning. This transaction reflects a standard practice of executives selling shares to cover tax liabilities associated with vesting equity awards.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time.
- It is standard practice for executives to sell a portion of their shares upon vesting to cover income tax obligations.
- The amount of shares sold for tax purposes varies depending on the individual's tax situation and the company's equity compensation plan.
- Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize RSUs as part of their executive compensation, and their executives similarly engage in stock transactions for tax purposes.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a routine sale of shares by an executive for tax purposes.
- The transaction does not directly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| October 31, 2023 | Date of original grant of time-based restricted stock units (RSUs) to Brady Priest. |
| November 2, 2023 | Date Form 4 was filed reporting the grant of RSUs. |
| January 31, 2025 | Date of transaction: Disposal of shares to cover tax obligations upon vesting of RSUs. |
| February 4, 2025 | Date of signature on the Form 4 filing. |
| October 31, 2025 | Final vesting date of the remaining RSUs, subject to continued service. |
Keywords
Clover Health, Brady Priest, SEC Form 4, Stock Disposal, Tax Obligations, Restricted Stock Units, CLOV, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.